Human sphingomyelin synthase 1 generates diacylglycerol in the presence and absence of ceramide via multiple enzymatic activities

FEBS Lett. 2023 Nov;597(21):2672-2686. doi: 10.1002/1873-3468.14735. Epub 2023 Sep 24.

Abstract

Sphingomyelin (SM) synthase 1 (SMS1), which is involved in lipodystrophy, deafness, and thrombasthenia, generates diacylglycerol (DG) and SM using phosphatidylcholine (PC) and ceramide as substrates. Here, we found that SMS1 possesses DG-generating activities via hydrolysis of PC and phosphatidylethanolamine (PE) in the absence of ceramide and ceramide phosphoethanolamine synthase (CPES) activity. In the presence of the same concentration (4.7 mol%) of PC and ceramide, the amounts of DG produced by SMS and PC-phospholipase C (PLC) activities of SMS1 were approximately 65% and 35% of total DG production, respectively. PC-PLC activity showed substrate selectivity for saturated and/or monounsaturated fatty acid-containing PC species. A PC-PLC/SMS inhibitor, D609, inhibited only SMS activity. Mn2+ inhibited only PC-PLC activity. Intriguingly, DG attenuated SMS/CPES activities. Our study indicates that SMS1 is a unique enzyme with PC-PLC/PE-PLC/SMS/CPES activities.

Keywords: D609; ceramide; ceramide phosphoethanolamine synthase; diacylglycerol; phosphatidylcholine-phospholipase C; sphingomyelin synthase.

MeSH terms

  • Ceramides*
  • Diglycerides
  • Humans
  • Phosphatidylcholines
  • Sphingomyelins*
  • Transferases (Other Substituted Phosphate Groups) / genetics

Substances

  • Ceramides
  • Diglycerides
  • phosphatidylcholine-ceramide phosphocholine transferase
  • Phosphatidylcholines
  • Sphingomyelins
  • Transferases (Other Substituted Phosphate Groups)
  • SGMS1 protein, human

Associated data

  • RefSeq/NM_147156.4